BWX Technologies, Inc. reports developments tied to its nuclear manufacturing, engineering, and services businesses for government and commercial customers. Recurring updates include U.S. Naval Nuclear Propulsion Program contracts, long-lead reactor and component manufacturing, commercial nuclear equipment, and work connected to nuclear fuel and uranium-enrichment capabilities.
Company news also covers operating and financial results for its Government Operations and Commercial Operations segments, capital actions, governance changes, and regulatory engagement involving nuclear licensing. BWXT’s recurring business themes span global security, clean energy, nuclear medicine, space exploration, and environmental restoration.
BWX Technologies (NYSE:BWXT) has begun manufacturing the reactor core for Project Pele, a 1.5-megawatt transportable microreactor for the Department of Defense. The innovative reactor, designed to fit in four 20-foot shipping containers, will provide reliable power for military bases for up to three years without refueling.
The project involves key partnerships with Rolls-Royce developing the power conversion module and Northrop Grumman providing the control module. The reactor will use TRISO fuel, a specialized HALEU fuel designed for extreme heat conditions. Project Pele aligns with Executive Order 14299, which mandates the operation of a nuclear reactor at a domestic military base by September 30, 2028.
BWX Technologies (NYSE:BWXT) has achieved a significant milestone in advanced nuclear fuel manufacturing with the completion of a chemical vapor infiltration (CVI) furnace installation. This advancement enables BWXT to produce enhanced TRISO nuclear fuel, described by the DOE as "the most robust nuclear fuel on Earth."
The new capability allows BWXT to load Uranium Nitride TRISO into additively manufactured fuel forms, resulting in higher uranium mass per unit volume than traditional TRISO compacts. This innovation promises more cost-effective fuel with longer reactor lifespans. The company currently produces both Uranium Oxy Carbide TRISO for Project Pele and UN TRISO for the Advanced Reactor Demonstration Program (ARDP), with plans to expand production to support the BWXT Advanced Nuclear Reactor (BANR) program.
BWX Technologies (NYSE: BWXT) has secured significant U.S. Naval Nuclear Propulsion Program contracts worth approximately $2.6 billion, including future year options, for manufacturing naval nuclear reactor components. The contracts primarily support Virginia and Columbia-class submarines and Ford-class aircraft carrier components, with deliveries scheduled over the next 6-8 years.
These new contracts build upon the $2.1 billion in awards announced in February. BWXT, with facilities across Ohio, Indiana, Tennessee, and Virginia, manufactures and assembles highly complex naval nuclear reactors, including large components, finely machined parts, and highly enriched uranium fuel.
BWX Technologies (NYSE:BWXT) has scheduled its second quarter 2025 earnings release and conference call for Monday, August 4, 2025. The company will release results after market close, followed by a conference call at 5:00 p.m. EDT.
Participants can join via webcast at investors.bwxt.com or by phone using the following dial-in numbers: (U.S.) 1-888-596-4144 and (International) 1-646-968-2525 with conference ID: 3934110.
BWXT is a Fortune 1000 and Defense News Top 100 company specializing in nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine, and space exploration. The company employs nearly 10,000 people across 20 major operating sites in the U.S., Canada, and the U.K.
BWX Technologies (NYSE: BWXT) has completed its acquisition of Kinectrics, Inc. on May 20, 2025. The strategic acquisition significantly enhances BWXT's capabilities in the commercial nuclear power market and medical isotopes sector. Kinectrics provides nuclear power plant lifecycle support services, particularly for CANDU reactors, and serves the transmission and distribution markets along with radiopharmaceutical isotope production.
The acquisition nearly doubles BWXT's Commercial Operations group workforce and expands its product and service portfolio. Kinectrics will operate as a BWXT subsidiary within the Commercial Operations segment, with David Harris continuing as president & CEO, reporting to BWXT Commercial Operations president John MacQuarrie.